Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.
about
Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment.Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin.
P2860
Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cure for thalassemia major - f ...... ansplantation to gene therapy.
@en
Cure for thalassemia major - f ...... ansplantation to gene therapy.
@nl
type
label
Cure for thalassemia major - f ...... ansplantation to gene therapy.
@en
Cure for thalassemia major - f ...... ansplantation to gene therapy.
@nl
prefLabel
Cure for thalassemia major - f ...... ansplantation to gene therapy.
@en
Cure for thalassemia major - f ...... ansplantation to gene therapy.
@nl
P2860
P1433
P1476
Cure for thalassemia major - f ...... ansplantation to gene therapy.
@en
P2093
Alok Srivastava
Ramachandran V Shaji
P2860
P304
P356
10.3324/HAEMATOL.2015.141200
P577
2016-12-01T00:00:00Z